Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Keryx Biopharmaceuticals
Keryx Biopharmaceuticals
(KERX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Auryxia
Ferric pyrophosphate citrate
2014-09-05
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Perifosine
myelodysplastic syndromes
,
myelodysplastic-myeloproliferative diseases
,
ovarian neoplasms
,
fallopian tube neoplasms
,
recurrence
,
myeloid leukemia acute
,
promyelocytic leukemia acute
,
congenital abnormalities
,
precursor cell lymphoblastic leukemia-lymphoma
,
biphenotypic leukemia acute
,
bcr-abl positive chronic myelogenous leukemia
,
megakaryoblastic leukemia acute
,
monocytic leukemia acute
,
myelomonocytic leukemia acute
,
myeloid leukemia chronic-phase
,
myeloid leukemia
,
myeloid leukemia accelerated phase
,
erythroblastic leukemia acute
,
blast crisis
,
myeloproliferative disorders
,
preleukemia
,
syndrome
,
neoplasms
,
sarcoma
,
kidney neoplasms
,
brain neoplasms
,
glioma
,
renal cell carcinoma
,
leukemia
,
lymphoma
,
colonic neoplasms
,
gastrointestinal stromal tumors
,
glioblastoma
,
astrocytoma
,
oligodendroglioma
,
breast neoplasms
,
non-small-cell lung carcinoma
,
waldenstrom macroglobulinemia
,
prostatic neoplasms
,
pancreatic neoplasms
,
carcinoma
,
gliosarcoma
,
chondrosarcoma
,
alveolar soft part sarcoma
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lung neoplasms
,
head and neck neoplasms
,
endometrial neoplasms
,
melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
colorectal neoplasms
Sulodexide
diabetic nephropathies
,
kidney diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use